Healthcare -
Biotechnology - NASDAQ - US
$ 20.905
-4.13 %
$ 1.03 B
Market Cap
-11.13
P/E
ELVN - OPERATING INCOME
Operating Income ELVN - Enliven Therapeutics, Inc.
-105 M
LAST VALUE
-64.17%
2 YEAR CAGR
-34.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR